The median onset of diarrhea/colitis typically occurs around 3 to 6 months after treatment with anti-PD-1/Programmed cell death-ligand 1 (PD-L1) agents, while earlier for anti-CTLA-4 agents at around 6 to 8 weeks (50, 51). The gene discussed is PDCD1; the disease is colitis.